Brief: Caplin Point Laboratories Unit Enters License And Supply Deal With Baxter Healthcare
08/04/2019 06:45
April 8 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* UNIT CAPLIN STERILES ENTERS LICENSE AND SUPPLY DEAL WITH
BAXTER
HEALTHCARE CORP FOR FIVE GENERIC INJECTABLE ANDAS
Source text: http://bit.ly/2uRTdyb
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees